Subsequent Event (Details) - USD ($) |
1 Months Ended | 3 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 15, 2020 |
May 04, 2020 |
Apr. 28, 2020 |
Apr. 23, 2020 |
Apr. 17, 2020 |
Apr. 02, 2020 |
Apr. 01, 2020 |
May 11, 2020 |
Apr. 30, 2020 |
Mar. 31, 2020 |
Mar. 31, 2019 |
Dec. 31, 2019 |
|
| Subsequent Event (Textual) | ||||||||||||
| Stock-based professional fees | $ (15,000) | $ (49,646) | ||||||||||
| Derivative liability | $ 1,310,654 | $ 890,410 | ||||||||||
| Convertible debt [Member] | ||||||||||||
| Subsequent Event (Textual) | ||||||||||||
| Warrants to purchase of common shares | 144,375 | |||||||||||
| Net proceeds | $ 44,187 | |||||||||||
| Exercise price | $ 0.10 | |||||||||||
| Derivative liability | $ 89,976 | |||||||||||
| Operations initial derivative expense | 35,789 | |||||||||||
| Fair value of warrants | $ 5,813 | |||||||||||
| Subsequent Event [Member] | ||||||||||||
| Subsequent Event (Textual) | ||||||||||||
| Number of aggregate common shares | 203,125 | 2,500,000 | ||||||||||
| Accrued interest | $ 10,470 | |||||||||||
| Fees | 500 | |||||||||||
| Convertible debt | $ 44,530 | |||||||||||
| Conversion of deferred stock | $ 16,250 | |||||||||||
| Aggregate principal amount | $ 280,000 | |||||||||||
| Note converted, description | The Company entered into two one-year advisory board agreements with two individuals for services to be rendered on the Company’s medical advisory board. In connection with these advisory board agreements, the Company issued an aggregate of 500,000 restricted common shares of the Company to these advisory board members. These shares vest on April 1, 2021. These shares were valued at $20,000, or $0.04 per common share, based on contemporaneous common share sales by the Company. In connection with this consulting agreement Company shall record stock-based consulting fees over the vesting period. | The Company closed a subscription agreement with an accredited investor (the "Investor") whereby the Investor purchased 7,000,000 unregistered shares of the Company's common stock for proceeds of $161,000, or $0.023 per share. | ||||||||||
| Description of promissory note | The Company entered into a Paycheck Protection Program Promissory Note (the "PPP Note") with respect to a loan of $156,200 (the "PPP Loan") from Comerica Bank. The PPP Loan was obtained pursuant to the Paycheck Protection Program (the "PPP") of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES act") administered by the U.S. Small Business Administration ("SBA"). The PPP Loan matures on April 28, 2022 and bears interest at a rate of 1.00% per annum. The PPP Loan is payable in 18 equal monthly payments of approximately $8,900 commencing November 1, 2020. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The Company may apply to have the loan forgiven pursuant to the terms of the PPP if certain criteria are met. | |||||||||||
| Subsequent Event [Member] | Convertible debt [Member] | ||||||||||||
| Subsequent Event (Textual) | ||||||||||||
| Aggregate principal amount | $ 57,750 | |||||||||||
| Warrants to purchase of common shares | 144,375 | |||||||||||
| Net proceeds | $ 50,000 | |||||||||||
| Original issue discount | 5,000 | |||||||||||
| Origination fees | $ 2,750 | |||||||||||
| Note bears interest rate | 12.00% | |||||||||||
| Due and payable date | Jan. 23, 2021 | |||||||||||
| Note converted, description | In accordance with the April 2020 and this Note, subject to the adjustments as defined in the April 2020 SPA and Note, the conversion price (the "Conversion Price") shall equal the lesser of: (i) the lowest Trading Price (as defined below) during the previous twenty-five Trading Day period ending on the latest complete Trading Day prior to the date of this Note, and (ii) the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company). The "Variable Conversion Price" shall mean 60% multiplied by the Market Price (as defined herein) (representing a discount rate of 40%). | |||||||||||
| Subsequent Event [Member] | Series A Preferred Stock [Member] | ||||||||||||
| Subsequent Event (Textual) | ||||||||||||
| Number of aggregate common shares | 593,023 | 618,182 | 1,782,097 | |||||||||
| Conversion of Stock, Shares Issued | 10,000 | 12,000 | 67,406 | |||||||||
| Accrued interest | $ 200 | $ 240 | $ 1,348 | |||||||||
| Preferred stock redemption value | $ 10,000 | $ 12,000 | $ 67,406 | |||||||||
| Restricted Stock Award Agreements [Member] | Subsequent Event [Member] | ||||||||||||
| Subsequent Event (Textual) | ||||||||||||
| Common stock, Par value | $ 0.04 | |||||||||||
| Restricted common shares | 6,750,000 | |||||||||||
| Restricted common shares, valued | $ 270,000 | |||||||||||
| Percentage of restricted shares | 100.00% | |||||||||||
| Employment Agreement [Member] | Subsequent Event [Member] | ||||||||||||
| Subsequent Event (Textual) | ||||||||||||
| Common stock, Par value | $ 0.04 | |||||||||||
| Restricted common shares | 200,000 | |||||||||||
| Date of grant value | $ 8,000 | |||||||||||